Maryland State Retirement & Pension System’s Madrigal Pharmaceuticals MDGL Stock Holding History

Maryland State Retirement & Pension System’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503K	Buy	+936	New	+$479K	0.01%	954

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Maryland State Retirement & Pension System's MDGL Position: Q2 2026 in Review

Maryland State Retirement & Pension System opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 936 shares worth $503K. The stake represents 0.01% of the portfolio and ranks #954 among its holdings.

413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Maryland State Retirement & Pension System held 936 shares of Madrigal Pharmaceuticals worth $503K as of Q2 2026.
Madrigal Pharmaceuticals was a new Maryland State Retirement & Pension System position in Q2 2026.
Madrigal Pharmaceuticals made up 0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #954 holding.
413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.